Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | KIAA1468 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-13 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-13 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-13 |
mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-13 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-13 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-13 |
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-13 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-13 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-12 |